Riskpilot← Back to searchSign inGet full accessNormedentia AB
ABDissolvedOrg 5565759015MalmöWholesale of pharmaceutical and medical goods · NACE 4646Est. 19990 employees
Revenue 2023
—
EBITDA margin
—
+9% vs 2022
Equity ratio
-1821.5%
Financial strength
Net profit 2023
SEK -5K
+13% vs 2022
| Revenue | — | — |
| EBITDA | SEK -6K | +9% |
| Net profit | SEK -5K | +13% |
| Total assets | SEK 19K | -49% |
| Equity | SEK -347K | -2% |
| Employees | 0 | — |
Legal name
Normedentia AB
Org number
5565759015
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
12 oktober 1999
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva inköp och försäljning av utrustning för dental- och medicinteknisk apparatur och därmed förenlig verksamhet.
Address
Malmö
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −8 | −7 | −7 | −6 | −6 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | −8 | −7 | −7 | −6 | −6 |
| Net financials | −188 | −40 | −188 | 0 | 0 |
| Profit before tax | −196 | −47 | −196 | −6 | −5 |
| Tax | −0 | −0 | −0 | — | — |
| Net profit | −196 | −47 | −196 | −6 | −5 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 263 | 220 | 43 | 37 | 19 |
| Equity | −93 | −140 | −336 | −342 | −347 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 356 | 360 | 379 | 379 | 366 |
| Total debt | 356 | 360 | 379 | 379 | 366 |
EBITDA margin
-558600.0%
This company
15.8%
Market median
-3535543% vs market
20192023
Equity ratio
-1821.5%
This company
38.2%
Market median
-4868% vs market
20192023
Return on equity
-533600.0%
This company
18.4%
Market median
-2900100% vs market
20192023
Net profit margin
-533600.0%
This company
8.1%
Market median
-6587754% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
1.05×
This company
0.62×
Market median
-69% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nortek - Laboratoriet AB
Normedentia AB Board members of Normedentia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Michéle Inge Persson | Deputy Board Member | 0 companies |
| Hans-Ove Lennart Persson | Board of Directors | 0 companies |